Alkaloid 2026-10-31
Cinchona bark 2026-10-31
Medicinal bark obtained from specified species of Cinchona; a historical source of quinine and related cinchona alkaloids.
Cinchonine 2026-10-31
A cinchona alkaloid less soluble in diethyl ether than quinine; this difference underlies a historical purity screen.
Seek and control the infective source, drain accessible collections, support failing organs, and recognise that established pyaemia had a very poor outlook before effective antibiotics. The historical term commonly described severe systemic illness, often after a wound or operation, with recurrent rigors and secondary abscesses. Modern explanations include bacteraemia, an infected thrombus producing septic embolism, and metastatic infection. It is misleading to reduce the condition to an inert quantity of pus freely floating through the blood.
In the 1864 setting, examine the original wound and any painful swollen region for retained infected material, an undrained abscess, dead tissue or obstructed drainage. An accessible collection calls for surgical drainage; a superficially healed wound should not conceal an undrained deeper focus. Remove obvious sources of continuing contamination, provide careful dressings, cleanliness, ventilation, nursing and tolerable nourishment, and relieve pain. Period practice used quinine and alcoholic stimulants as supportive remedies. A surgical report covering July 1863 to October 1864 records these measures in the Royal Infirmary; its publication in 1865 documents the period rather than supplying an Oxford model answer.[ref]
Royal Infirmary surgical ward report (1863–1864). p. 111: wound cleanliness, local applications and quinine and stimulants in pyaemia
Such measures did not reliably sterilise the blood or inaccessible secondary abscesses. Neither repeated purging nor bloodletting has a sound role in an already depleted, seriously infected person. Later organised surgical antisepsis should not be presented as an established system available at this examination.Current care treats the presentation as possible sepsis with disseminated infection. Assess airway, breathing, circulation, mental state and organ function urgently. Obtain appropriate blood cultures and source samples without delaying necessary antibiotic treatment; investigate the original wound and likely secondary sites. Ultrasonography or other imaging can locate a collection for drainage. Persistent bacteraemia, embolic manifestations or a new heart murmur should prompt assessment for infective endocarditis, often including echocardiography. Source control may require drainage, removal of infected material or debridement. Initial antibiotics are chosen for the likely source and resistance risks, then narrowed using microbiological evidence.
Provide oxygen therapy when needed and carefully reassessed intravenous fluids; persistent circulatory failure requires critical-care treatment rather than indiscriminate fluid loading. Monitor urine output, renal function, blood pressure and response to treatment. The modern prognosis depends on source, organ injury and speed and adequacy of treatment, so the historical description alone does not support a numerical prediction.[ref]
Suspected sepsis in people aged 16 or over by NICE. NG253, recognition, source investigation and antibiotic, intravenous-fluid and oxygen recommendations
For December 1865 the relevant official preparations are those of the 1864 British Pharmacopoeia; dose ranges must come from contemporary prescribing evidence, not be borrowed from later editions. The first edition specified identities and preparations without supplying a universal clinical dose for every article. The following are historical adult quantities from The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865), using its British entries rather than bracketed United States formulas. They are not current prescribing instructions or established safe limits. “Grain” is a unit of mass; “minim”, fluid drachm and fluid ounce are units of volume. One Imperial fluid drachm contains 60 minims, and one fluid ounce contains eight fluid drachms. A minim is not an arbitrary drop.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). introduction, British weights and measures; posological table
For arsenic, distinguish the elemental substance from its medicinal compounds. The relevant series comprises Acidum Arseniosum, Liquor Arsenicalis, Sodae Arsenias, Liquor Sodae Arseniatis and Ferri Arsenias. The contemporary ranges are arsenic trioxide about 1/60–1/12 grain; arsenical solution 2–5 minims, occasionally 10; crystalline sodium arsenate 1/12–1/2 grain, or its dried salt 1/20–1/4 grain; its official solution 5–30 minims; ferrous arsenate 1/10–1/8 grain. Hydrated and dried salts cannot be exchanged grain for grain. The two official arsenical solutions each contain four grains of their specified ingredient per fluid ounce, but the ingredients are different. The solution of arsenic and mercury discussed alongside them was non-official, and Liquor Arsenici Hydrochloricus was an addition in 1867: neither belongs in an unqualified list of 1864 preparations.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). arsenious acid, sodium arsenate, ferrous arsenate; posological table
[ref]For copper, the medicinal article is purified Cupri Sulphas, copper sulfate: 1/4–2 grains as a historical astringent or tonic, 5–8 grains as a historical emetic. An external solution was described as 1–10 grains or more per fluid ounce, depending on the intended local action. The anhydrous test reagent and copper compounds listed among analytical materials are not additional ordinary internal preparations. Neither the historical emetic use nor an external concentration authorises modern oral use.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). purified copper sulfate, medicinal doses and distinction from analytical copper salts
For opium, the contemporary monograph gives powdered opium and Extractum Opii, 1/4–3 grains or more; Extractum Opii Liquidum, Tinctura Opii and Vinum Opii, 4–40 minims or more; Tinctura Camphorae cum Opio, 1–2 fluid drachms. These are the author's reported ranges, not maxima. His summary table differs, listing 3–30 minims for liquid extract and 1/2–4 grains for powdered opium; that internal variation should remain visible rather than being converted into an invented single official limit.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Action of the other constituents of opium, Dose; compare Posological table
The compound oral opium preparations require their own quantities: Pilula Opii, 2 1/2 grains upwards; Pilula Plumbi cum Opio, 4–8 grains; Pulvis Cretae Aromaticus cum Opio, 10–60 grains; Pulvis Ipecacuanhae cum Opio, a reference quantity of 5 grains upwards; Pulvis Kino cum Opio, 10 grains upwards; Trochisci Opii, one to four lozenges. In the same order, the pill masses and powders contain approximately one part opium in 5, 8, 40, 10 and 20; each opium lozenge contains 1/10 grain. “Upwards” in the historical source does not establish a safe upper boundary: the required opium content, other ingredients and circumstances controlled the quantity. The lead-containing pill has an additional toxic constituent. Enema Opii supplies about one grain of opium in the official two-fluid-ounce enema; this is a rectal preparation, not an oral measure.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). opium preparations; posological table and table of ingredient proportions
The external opium preparations, Emplastrum Opii, Linimentum Opii and Unguentum Gallae cum Opio, have no ordinary swallowed dose. For completeness the official isolated alkaloid series was Morphiae Hydrochloras, Liquor Morphiae Hydrochloratis, Suppositoria Morphiae, Trochisci Morphiae and Trochisci Morphiae et Ipecacuanhae. The reported historical quantities are morphine hydrochloride, 1/8–1 grain; its solution, 20 minims to two fluid drachms in the monograph; one suppository containing 1/4 grain; either kind of morphine lozenge, one to four, each containing 1/36 grain. The summary table gives a narrower upper quantity of one fluid drachm for the solution. These large historical ranges must not be interpreted as safe for a person without opioid tolerance. The solution contains four grains per fluid ounce. Neither a morphine-acetate preparation added later nor a non-official compound confection should be substituted for this 1864 series.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). opium, morphine preparations, doses and ingredient proportions
For belladonna, Extractum Belladonnae, 1/6–1 grain; Tinctura Belladonnae, 5–30 minims. Emplastrum Belladonnae, Linimentum Belladonnae and Unguentum Belladonnae are external preparations, not additional oral doses. The associated Atropia, Liquor Atropiae and Unguentum Atropiae likewise require their route to be stated: this author specifically discourages routine internal atropine administration and describes ophthalmic use of the solution. Its strength is four grains per fluid ounce; the ointment contains eight grains per ounce. These are historical formulation strengths, not a modern eye-drop or oral prescription. The atropine-sulfate series introduced in 1867 is not the 1864 series.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Solanaceae and continuation; Belladonna and Atropia in the ingredient table
For Strychnia, strychnine, the historical range was 1/32–1/8 grain; Liquor Strychniae, 5–15 minims, the solution containing four grains per fluid ounce. If the botanical preparations yielding the alkaloid are included, powdered nux vomica, 1–3 grains; Extractum Nucis Vomicae, 1/4–2 grains; Tinctura Nucis Vomicae, 10–30 minims. The American editor already warned that the two-grain extract quantity was very large and that more than half a grain commonly risked adverse effects. Keeping that qualification is more faithful than presenting the printed upper range as routine or safe.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Loganiaceae, solution, doses and editorial footnote
For cinchona bark, powdered yellow, pale or red bark, 10–60 grains; Decoctum Cinchonae Flavae and Infusum Cinchonae Flavae, 1–2 fluid ounces; Extractum Cinchonae Flavae Liquidum, 10–60 minims; Tinctura Cinchonae Flavae and Tinctura Cinchonae Composita, 1–2 fluid drachms. The associated Tinctura Quiniae Composita was given at 1–2 fluid drachms. The isolated official quinine sulfate, Quiniae Sulphas, was listed at 1–10 grains, with larger quantities discussed for particular intermittent fevers. Ferri et Quiniae Citras, the official iron-and-quinine preparation, was listed at 5–20 grains. Other cinchona alkaloids discussed as possible remedies do not thereby become official preparations. Strength in bark equivalents also does not guarantee a fixed amount of extracted quinine.[ref]
The Essentials of Materia Medica and Therapeutics by Alfred Baring Garrod (1865). Cinchonaceae Part 4; Action of the different kinds of cinchona barks, Dose; posological table, citrate of iron and quinine
These figures answer a historical materia medica question. Current drug safety requires the exact modern product, route, indication and patient factors; poisonous nineteenth-century “tonics” and emetics are not revived by accurate transcription of their period doses. Strychnine can cause severe painful convulsions; opioids can depress breathing; and inorganic arsenic is a toxic and carcinogenic exposure. Those facts undermine any reading of the historical numbers as a self-treatment schedule.[ref]
Strychnine by the Centers for Disease Control and Prevention. clinical effects and emergency treatment
[ref]Opioid overdose by WHO. respiratory depression and overdose
[ref]Arsenic by WHO. acute effects, chronic exposure and carcinogenicity
The main distinction is between metallic iron, iron(II) preparations, iron(III) preparations, and mixed iron oxides. The old prefixes “proto-” and “per-” ordinarily distinguish the lower and higher oxidation states here. “Peroxide of iron” means the historical iron(III) oxide preparation, not a modern peroxide containing an oxygen–oxygen bond.
The principal medicinal preparations can be grouped by the chemical form supplied:
- Iron(II) sulfate: Ferri sulphas, its granulated form, and its dried form supply iron(II). The ordinary and granulated salts are represented as ; the 1867 dried preparation is represented as . Drying principally changes the water of crystallization, rather than converting iron(II) into iron(III).
- Iron(II) carbonate: Ferri carbonas saccharata, the carbonate pill, and the compound iron mixture contain freshly formed iron(II) carbonate, . Exposure to air introduces higher iron oxides; sucrose helps preserve the lower oxidation state. Thus the saccharated material is a protected preparation rather than a pure, permanently stable salt.
- Iron(II) iodide: Ferri iodidum, its syrup, and its pill supply mainly . The historical solid includes water of crystallization and some iron oxide; the syrup again employs sucrose to retard deterioration.
- Iron(II) phosphate: Ferri phosphas and the corresponding syrup supply the lower iron phosphate, conventionally . The official precipitated material is partly oxidized, so describing the actual powder as chemically pure iron(II) phosphate would be too strong.
- Iron(III) chloride: the solution and tincture of “perchloride of iron” contain the higher chloride, , in an acidic liquid. This historical “perchloride” is unrelated to a perchlorate.
- Iron(III) nitrate: solution of “pernitrate of iron” contains the higher nitrate, , again in an acidic liquid. The solution of “persulphate” used to manufacture several other preparations supplies iron(III) sulfate, ; it is useful to distinguish this manufacturing reagent from the widely administered iron(II) sulfate.
- Iron(III) with organic acids: citrate of iron and ammonium, and tartarated iron, contain the higher iron in citrate or tartrate combinations. Citrate of iron and quinine is prepared from a higher iron compound, but should not be assumed to contain exclusively iron(III): the 1867 monograph reports blue reactions with both potassium ferrocyanide and potassium ferricyanide, consistent with an iron(II) component as well. The tartarated preparation also contains potassium; citrate of iron and quinine is made with Ammonia. They should be described as soluble pharmaceutical combinations, without pretending that every historical batch had a single simple molecular formula. The acetate tincture similarly contains the higher iron combined with acetic acid.
- Iron oxides: Ferri peroxidum hydratum (dried hydrated “peroxide”) and Ferri peroxidum humidum (the moist material) contain iron(III) as iron(III) oxide or hydrated iron(III) oxide. The magnetic oxide is a mixed iron(II)–iron(III) oxide preparation; expresses the ideal mixed oxide, rather than a claim that the historical hydrated powder was pure crystalline magnetite.
- Metallic iron: Ferrum redactum, used also in lozenges, contains finely divided iron in oxidation state zero together with magnetic oxide. The official preparation is therefore not all elemental iron. Iron wine made by contacting wire with wine obtains a dissolved tartrate-containing iron preparation from reaction with the wine's acids; the wire placed in the vessel should not be confused with the chemical form in the liquid ultimately dispensed.
These identifications follow the historical monographs, rather than the names of present commercial supplements.[ref]
British Pharmacopoeia by the General Medical Council (1867). “Ferri carbonas saccharata” through “Ferrum tartaratum”, pp. 130–141; the iron solutions, pp. 186–189; “Vinum ferri”, p. 367
A green iron(II) sulfate solution gives the characteristic blue reaction with potassium ferricyanide, whereas the higher iron solutions give blue with potassium ferrocyanide. Those diagnostic reactions explain why the official tests distinguish the two oxidation states; the historical colour test alone does not establish every detail of a complex preparation's composition.Prepare quinine sulfate by acidic extraction of cinchona bark, alkaline precipitation of the quinine base, conversion into the sulfate, and purification by crystallization. “Quinia” is the historical name for quinine.
The 1867 process starts with one pound of yellow cinchona bark in coarse powder, three fluid ounces of hydrochloric acid, four pints of solution of sodium hydroxide, and sufficient distilled water and diluted sulfuric acid. The hydrochloric acid is diluted with ten pints of distilled water. The bark is first moistened with diluted sulfuric acid, macerated for twenty-four hours with occasional stirring, and then exhausted in a percolator with the diluted hydrochloric acid. The historical endpoint is disappearance of the bitter character of the emerging liquid. This describes the period's test, not an instruction to taste an unidentified medicinal material.[ref]
British Pharmacopoeia by the General Medical Council (1867). “Quiniæ sulphas”, pp. 268–269, ingredients and extraction
The soluble alkaloid salts enter the percolate. Adding solution of sodium hydroxide liberates the much less water-soluble quinine base. After settling, the liquid is decanted and the precipitate collected on a filter and washed with cold distilled water until the washings cease to be coloured. The precipitate is then treated warm with distilled water and diluted sulfuric acid, added gradually to obtain a neutral liquid with nearly all the precipitate dissolved. The hot solution is filtered through paper, the filter washed with distilled water, and the filtrate concentrated until a surface film appears. It is then set aside for crystallization; the crystals are dried on filter paper without applied heat. This is a separation of a naturally occurring alkaloid, not a synthesis of the quinine skeleton.
Writing for the quinine base, the central changes are:The successive changes in solubility explain the apparatus: a percolator washes soluble salts out of the powder; a filter retains the liberated base; a heated porcelain vessel dissolves the crude base as its sulfate; cooling then recovers the less soluble crystals. Other cinchona alkaloids can accompany the product, which is why appearance and bitterness are insufficient evidence of purity.
- Appearance and solubility: filiform, silky, white crystals, sparingly soluble in water, with the characteristic bluish appearance of the solution. A little dilute acid increases solubility. The visible blue phenomenon is associated with quinine fluorescence.
- Sulfate identity: barium chloride gives a white precipitate insoluble in nitric acid. The precipitate is barium sulfate.
- Quinine identity: treating the solution first with chlorine water and then with Ammonia gives an emerald-green colour, the thalleioquin test. A positive colour reaction establishes a characteristic chemical response, rather than proving that no other alkaloid is present.
- Strong-acid colour test: dissolution in pure sulfuric acid gives only a faint yellowish tint, with no further colour change on gentle warming. Marked colouring suggests foreign organic matter, such as sucrose or other readily altered material.
- Acid dissolution and liberation of the base: ten grains with ten minims of diluted sulfuric acid and half a fluid ounce of water form a complete solution; Ammonia then gives a white precipitate. Material insoluble under the acid conditions would fail the dissolution requirement.
- Ether separation: the precipitated base must pass into diethyl ether on shaking the whole with half a fluid ounce of diethyl ether, without crystalline matter remaining at the boundary between the two liquid layers. Less ether-soluble cinchona alkaloids, particularly cinchonine, can leave material at this boundary. This is a period screening test, not a modern quantitative determination of every related impurity.
- Water of crystallization: twenty-five grains lose 3.6 grains on drying at , equivalent to . This checks excessive moisture or a materially different degree of hydration.
The historical quantity and endpoint requirements belong to the 1867 monograph.[ref]
British Pharmacopoeia by the General Medical Council (1867). “Quiniæ sulphas”, pp. 268–269, “Characters and Tests”
Its formula represents the then-described heptahydrate; the current “Quinine sulfate” instead specifies a dihydrate and modern tests for related cinchona alkaloids. The modern specification explains that distinction; the exam's historical tests remain those listed above.[ref]International Pharmacopoeia by the World Health Organization. 12th edition, 2024, “Quinine sulfate (Quinini sulfas)”, formula, loss on drying and related cinchona alkaloids
Quinine fluorescence 2026-10-31
Blue fluorescence of suitably acidified quinine solutions, used in identifying quinine and illustrating fluorescence.
Quinine sulfate 2026-10-31
Thalleioquin test 2026-10-31